Colgate-Palmolive Company $CL Shares Acquired by Ycg LLC

Ycg LLC boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 3.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 209,048 shares of the company’s stock after acquiring an additional 7,874 shares during the period. Colgate-Palmolive accounts for about 1.3% of Ycg LLC’s investment portfolio, making the stock its 26th largest position. Ycg LLC’s holdings in Colgate-Palmolive were worth $16,711,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CL. Grimes & Company Inc. grew its position in shares of Colgate-Palmolive by 1.0% in the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after purchasing an additional 118 shares during the last quarter. RFG Advisory LLC lifted its stake in Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after buying an additional 123 shares in the last quarter. Tiemann Investment Advisors LLC grew its holdings in Colgate-Palmolive by 2.1% during the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after buying an additional 125 shares during the last quarter. Redhawk Wealth Advisors Inc. increased its position in Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after buying an additional 129 shares in the last quarter. Finally, Westside Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CL. The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Bank of America lowered their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research note on Tuesday, December 9th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating for the company in a research note on Thursday, January 8th. Finally, Morgan Stanley reduced their price target on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a research note on Monday, November 3rd. Eleven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $89.44.

Colgate-Palmolive Stock Up 0.2%

Shares of CL opened at $84.49 on Friday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company’s fifty day moving average is $79.39 and its two-hundred day moving average is $81.82. The firm has a market cap of $68.10 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 5.72 and a beta of 0.30. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same period last year, the company posted $0.91 EPS. The business’s quarterly revenue was up 1.9% on a year-over-year basis. Analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 58.26%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.